The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 study of ziftomenib (KO-539) in combination with venetoclax or venetoclax/azacitidine or standard induction cytarabine/daunorubicin (7+3) chemotherapy for the treatment of patients with acute myeloid leukemia.
 
Amer Methqal Zeidan
Honoraria - Abbvie; Acceleron Pharma; Agios; Astellas Pharma; BeyondSpring Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb; Bristol-Myers Squibb/Celgene; Daiichi Sankyo; Epizyme; Geron; Ionis Pharmaceuticals; Jazz Pharmaceuticals; Novartis; Otsuka; Pfizer; Seagen; Taiho Pharmaceutical; Takeda; Trovagene
Consulting or Advisory Role - Abbvie; Acceleron Pharma; Agios; Astellas Pharma; BeyondSpring Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Epizyme; Geron; Incyte; Ionis Pharmaceuticals; Jazz Pharmaceuticals; Novartis; Otsuka; Pfizer; Seagen; Taiho Pharmaceutical; Takeda
Research Funding - Abbvie (Inst); ADC Therapeutics (Inst); Aprea AB (Inst); Astex Pharmaceuticals (Inst); AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Incyte (Inst); Novartis (Inst); Pfizer (Inst); Takeda (Inst); Trovagene (Inst)
Travel, Accommodations, Expenses - Celgene; Novartis; Pfizer; Trovagene
 
Amir Tahmasb Fathi
Consulting or Advisory Role - Abbvie; Agios; Amgen; Astellas Pharma; Autolus; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; EnClear Therapies; FORMA Therapeutics; Genentech; Immunogen; Ipsen; Kite, a Gilead company; Mablytics; MorphoSys; Novartis; Orum Therapeutics; Pfizer; PureTech; Rigel; SERVIER; Takeda
Research Funding - Abbvie (Inst); agios (Inst); Bristol-Myers Squibb (Inst); SERVIER (Inst)
 
Ghayas C. Issa
Consulting or Advisory Role - Kura Oncology; Novartis
Research Funding - Kura Oncology (Inst); Novartis (Inst); Syndax (Inst)
 
Harry Paul Erba
Consulting or Advisory Role - Abbvie/Genentech; Agios; Amgen; Astellas Pharma; Bristol-Myers Squibb/Celgene; Celgene; Daiichi Sankyo; Glycomimetics; Immunogen; Incyte; Janssen Oncology; Jazz Pharmaceuticals; Kura Oncology; Macrogenics; Novartis; Pfizer; Sumitomo Dainippon Pharma Oncology; Takeda; Trillium Therapeutics
Speakers' Bureau - Abbvie; Agios; Bristol Myers Squibb Foundation; Incyte; Jazz Pharmaceuticals; Novartis; SERVIER
Research Funding - Abbvie (Inst); Abbvie (Inst); Agios (Inst); ALX Oncology (Inst); Amgen (Inst); Aptose Biosciences (Inst); Daiichi Sankyo (Inst); FORMA Therapeutics (Inst); Gilead/Forty Seven (Inst); Glycomimetics (Inst); Immunogen (Inst); Jazz Pharmaceuticals (Inst); Macrogenics (Inst); Novartis (Inst); PTC Therapeutics (Inst); SERVIER; Sumitomo Dainippon Pharma Oncology (Inst)
Other Relationship - Bristol-Myers Squibb/Celgene; Celgene; Glycomimetics
(OPTIONAL) Uncompensated Relationships - Daiichi Sankyo
 
Julie Ahsan
Employment - Kura Oncology
Stock and Other Ownership Interests - Kura Oncology
Travel, Accommodations, Expenses - Kura Oncology
 
Daniel Corum
Employment - Kura Oncology
Stock and Other Ownership Interests - Kura Oncology
 
Blake E. Tomkinson
Employment - Kura Oncology
Stock and Other Ownership Interests - Kura Oncology
Consulting or Advisory Role - Kura Oncology
Patents, Royalties, Other Intellectual Property - Kura Oncology
Travel, Accommodations, Expenses - Kura Oncology
 
Tom Kozlek
Employment - Kura Oncology
Stock and Other Ownership Interests - Kura Oncology
Travel, Accommodations, Expenses - Kura Oncology
 
Mollie Leoni
Employment - Kura Oncology; Kyowa Kirin International
Stock and Other Ownership Interests - Kura Oncology
Travel, Accommodations, Expenses - Kura Oncology; Kura Oncology; Kyowa Kirin International
 
Eunice S. Wang
Consulting or Advisory Role - Abbvie; Astellas Pharma; Celgene/Bristol-Myers Squibb; Genentech; Gilead Sciences; GlaxoSmithKline; Jazz Pharmaceuticals; Kite/Gilead; Novartis; Pfizer; Pharmaessentia; PTC Therapeutics; Stemline Therapeutics; Takeda
Speakers' Bureau - Astellas Pharma; dava oncology; Kite, a Gilead company; Pfizer; Stemline Therapeutics